Clinical Trials
18
Active:0
Completed:11
Trial Phases
3 Phases
Phase 1:1
Phase 3:6
Phase 4:9
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Phase 4
9 (56.3%)Phase 3
6 (37.5%)Phase 1
1 (6.3%)Study on Booster Immunization With Varicella Vaccine at Different Intervals
- First Posted Date
- 2025-05-29
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Target Recruit Count
- 412
- Registration Number
- NCT06994052
- Locations
- 🇨🇳
Jiangsu Provincial Center for Disease control and Prevention, Nanjing, Jiangsu, China
Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)
Phase 4
Completed
- Conditions
- VaricellaInfluenza Vaccine
- Interventions
- First Posted Date
- 2025-05-23
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Target Recruit Count
- 899
- Registration Number
- NCT06987942
- Locations
- 🇨🇳
Jiangsu Provincial Center for Disease control and Prevention, Nanjing, Jiangsu, China
Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine
Phase 4
Not yet recruiting
- Conditions
- Varicella (chickenpox)MMR VaccineDTaP Vaccine
- Interventions
- Biological: Vaicella Vaccine+DTaP on Day 0, MMR on Day 30Biological: Varicella vaccine+MMR on Day 0，DTaP on Day 30
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Target Recruit Count
- 720
- Registration Number
- NCT06891872
- Locations
- 🇨🇳
Chongqing Center for Disease Control and Prevention, Chongqing, China
An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Target Recruit Count
- 414
- Registration Number
- NCT06484686
- Locations
- 🇨🇳
Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan, China
Correlation of Protection Against Varicella in an Exploratory Study
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Target Recruit Count
- 400
- Registration Number
- NCT06482216
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found